JPWO2019212050A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019212050A5
JPWO2019212050A5 JP2020517071A JP2020517071A JPWO2019212050A5 JP WO2019212050 A5 JPWO2019212050 A5 JP WO2019212050A5 JP 2020517071 A JP2020517071 A JP 2020517071A JP 2020517071 A JP2020517071 A JP 2020517071A JP WO2019212050 A5 JPWO2019212050 A5 JP WO2019212050A5
Authority
JP
Japan
Prior art keywords
active ingredient
yeast cells
separated
microcapsules
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020517071A
Other languages
Japanese (ja)
Other versions
JP7341128B2 (en
JPWO2019212050A1 (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/018037 external-priority patent/WO2019212050A1/en
Publication of JPWO2019212050A1 publication Critical patent/JPWO2019212050A1/en
Publication of JPWO2019212050A5 publication Critical patent/JPWO2019212050A5/ja
Application granted granted Critical
Publication of JP7341128B2 publication Critical patent/JP7341128B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

限定されるわけではないが、本発明は以下の態様を含む
[態様1]
マイクロカプセルの製造方法であって、
酵母細胞を熱水処理し、内容成分が菌体外に放出され、内容成分が分離され残留した酵母細胞を製造する工程、
前記内容成分が分離され残留した酵母細胞を第1有効成分とし、これに第2有効成分を内包させる工程、
を含む、
ただし、内容成分が分離され残留した酵母細胞に酸処理を施さない、
前記製造方法。
[態様2]
前記内容成分が分離され残留した酵母細胞にプロテアーゼ及び/又はセルラーゼ添加処理を施す工程を含む、態様1の方法。
[態様3]
前記内容成分が分離され残留した酵母細胞にプロテアーゼ及び/又はセルラーゼ添加処理を施す工程の前、後、又は同時に乳化剤を添加する工程を含む、態様2に記載の方法。
[態様4]
乳化剤が、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、レシチン及びサポニンからなる群より選択される、態様3に記載の方法。
[態様5]
第2有効成分が、香料、香辛料抽出物、香味油、動物性油脂及び植物性油脂からなる群から選択される脂溶性物質である、態様1-4のいずれか1項に記載の方法。
[態様6]
内容成分が分離され残留した酵母細胞が、乾燥された状態のものである、態様1-5のいずれか1項に記載の方法。
[態様7]
内容成分が分離され残留した酵母細胞が、タンパク質成分を45重量%-70重量%の範囲で含有する、態様1-6のいずれか1項に記載の方法。
[態様8]
前記内容成分が分離され残留した酵母細胞に第2有効成分を内包させる工程が、内容成分が分離され残留した酵母細胞、第2有効成分及び水分を混合して攪拌することを含む、態様1-7のいずれか1項に記載の方法。
[態様9]
前記内容成分が分離され残留した酵母細胞に第2有効成分を内包させる工程が、内容成分が分離され残留した酵母細胞、第2有効成分及び水分を混合して攪拌し、得られた分散液を乾燥することを含む、態様1-8のいずれか1項に記載の方法。
[態様10]
内容成分が分離され残留した酵母細胞と第2有効成分の混合割合が、4:1-1:1の範囲である、態様8又は9に記載の方法。
[態様11]
攪拌時間が1時間以上8時間以内である、態様8-10のいずれか1項に記載の方法。
[態様12]
攪拌温度が25℃以上50℃未満である、態様8-11のいずれか1項に記載の方法。
[態様13]
第2有効成分の包括効率が少なくとも40%である、態様1-12のいずれか1項に記載の方法。
[態様14]
態様1-13のいずれか1項に記載の方法により製造された、内容成分が分離され残留した酵母細胞及び第2有効成分を含む、マイクロカプセル。
[態様15]
酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、第2有効成分の徐放性が向上している、態様14に記載のマイクロカプセル。
[態様16]
酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、同等の酸化安定性である、態様15に記載のマイクロカプセル。
[態様17]
第2有効成分を5重量%以上含む、態様14-16のいずれか1項に記載のマイクロカプセル。
[態様18]
第2有効成分が香料、香辛料抽出物、動物性油脂、香味油及び植物性油脂からなる群から選択される脂溶性物質である、態様14-17のいずれか1項に記載のマイクロカプセル。
[態様19]
ペースト状である、態様14-18のいずれか1項に記載のマイクロカプセル。
[態様20]
冷蔵保存され得る、態様14-19のいずれか1項に記載のマイクロカプセル。
[態様21]
態様14-20のいずれか1項に記載のマイクロカプセルを含む、食品又は飲料の風味向上剤。
[態様22]
態様14-20のいずれか1項に記載のマイクロカプセル、あるいは、態様21に記載の風味向上剤を含む、食品又は飲料。
[態様23]
レトルト食品である、態様22に記載の食品。
[態様24]
(1)態様1-13のいずれか1項に記載の方法により製造された、内容成分が分離され残留した酵母細胞及び第2有効成分を含む、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を含む、植物性タンパク質臭を抑制するための組成物。
[態様25]
(1)態様1-13のいずれか1項に記載の方法により製造された、内容成分が分離され残留した酵母細胞及び第2有効成分を含む、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を含む、食品又は飲料。
[態様26]
(1)態様1-13のいずれか1項に記載の方法により製造された、内容成分が分離され残留した酵母細胞及び第2有効成分を含む、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を添加することを含む、植物性タンパク質臭を抑制するための方法。
The present invention includes, but is not limited to, the following aspects [Aspect 1].
It ’s a method of manufacturing microcapsules.
A process of treating yeast cells with hot water, releasing the content components to the outside of the cells, separating the content components, and producing residual yeast cells.
A step of using yeast cells from which the above-mentioned content components have been separated and remaining as the first active ingredient and incorporating the second active ingredient into the first active ingredient.
including,
However, the yeast cells from which the content components have been separated and remain are not treated with acid.
The manufacturing method.
[Aspect 2]
The method of embodiment 1, comprising a step of subjecting yeast cells from which the content components have been separated and remaining to a protease and / or cellulase addition treatment.
[Aspect 3]
The method according to aspect 2, comprising a step of adding an emulsifier before, after, or at the same time as applying a protease and / or cellulase addition treatment to the yeast cells from which the content components have been separated and remained.
[Aspect 4]
The method according to aspect 3, wherein the emulsifier is selected from the group consisting of glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, sucrose fatty acid ester, lecithin and saponin .
[Aspect 5]
The method according to any one of aspects 1-4, wherein the second active ingredient is a fat-soluble substance selected from the group consisting of fragrances, spice extracts, flavor oils, animal fats and oils, and vegetable fats and oils.
[Aspect 6]
The method according to any one of aspects 1-5, wherein the yeast cells from which the content components have been separated and remain are in a dried state.
[Aspect 7]
The method according to any one of aspects 1-6, wherein the yeast cells from which the content components have been separated and remain contain the protein components in the range of 45% by weight to 70% by weight.
[Aspect 8]
The step of encapsulating the second active ingredient in the yeast cells from which the content component has been separated and remaining comprises mixing and stirring the yeast cells, the second active ingredient and water from which the content component has been separated and remaining. The method according to any one of 7.
[Aspect 9]
In the step of encapsulating the second active ingredient in the yeast cells from which the content component was separated and remained, the yeast cells from which the content component was separated and remained, the second active ingredient and water were mixed and stirred, and the obtained dispersion was obtained. The method according to any one of aspects 1-8, comprising drying.
[Aspect 10]
The method according to aspect 8 or 9, wherein the mixing ratio of the yeast cells in which the content component is separated and remains and the second active ingredient is in the range of 4: 1-1: 1.
[Aspect 11]
The method according to any one of aspects 8-10, wherein the stirring time is 1 hour or more and 8 hours or less.
[Aspect 12]
The method according to any one of aspects 8-11, wherein the stirring temperature is 25 ° C. or higher and lower than 50 ° C.
[Aspect 13]
The method according to any one of aspects 1-12, wherein the comprehensive efficiency of the second active ingredient is at least 40%.
[Aspect 14]
A microcapsule produced by the method according to any one of aspects 1-13, which comprises yeast cells from which the content component has been separated and remains, and a second active ingredient.
[Aspect 15]
The microcapsule according to aspect 14, wherein the sustained release property of the second active ingredient is improved as compared with the microcapsules obtained by using yeast cells from which the content component has been separated and remained, which has been subjected to acid treatment.
[Aspect 16]
The microcapsule according to aspect 15, which has the same oxidative stability as the microcapsules obtained by using yeast cells which have been subjected to acid treatment and whose contents have been separated and remained.
[Aspect 17]
The microcapsule according to any one of aspects 14-16, which comprises 5% by weight or more of the second active ingredient.
[Aspect 18]
The microcapsule according to any one of aspects 14-17, wherein the second active ingredient is a fat-soluble substance selected from the group consisting of fragrances, spice extracts, animal fats and oils, flavor oils and vegetable fats and oils.
[Aspect 19]
The microcapsule according to any one of aspects 14-18, which is in the form of a paste.
[Aspect 20]
The microcapsule according to any one of aspects 14-19 , which can be stored refrigerated.
[Aspect 21]
A food or beverage flavor enhancer comprising the microcapsules according to any one of aspects 14-20.
[Aspect 22]
A food or beverage comprising the microcapsules according to any one of aspects 14-20 or the flavor enhancer according to aspects 21.
[Aspect 23]
The food according to aspect 22, which is a retort food.
[Aspect 24]
(1) Microcapsules produced by the method according to any one of aspects 1-13, containing yeast cells and a second active ingredient from which the content component has been separated and remained, and (2) suppression of vegetable protein odor. A composition for suppressing the odor of vegetable protein, which comprises an effective substance.
[Aspect 25]
(1) Microcapsules produced by the method according to any one of aspects 1-13, containing yeast cells and a second active ingredient from which the content component has been separated and remained, and (2) suppression of vegetable protein odor. Foods or beverages, including those that have an effect.
[Aspect 26]
(1) Microcapsules produced by the method according to any one of aspects 1-13, containing yeast cells and a second active ingredient from which the content component has been separated and remained, and (2) suppression of vegetable protein odor. A method for suppressing the odor of vegetable protein, which comprises adding an effective substance.

図1は、酵母細胞(標品2-D)の酵母分散液濃度(固形分濃度)(重量%)とフレーバー包括率(mg/g粉末マイクロカプセル)(左縦軸)及び含水率(右縦軸)の関係を示す。黒丸は包括率、白丸は、含水率を示す。FIG. 1 shows the yeast dispersion concentration (solid content concentration) (% by weight), flavor inclusion ratio (mg / g powder microcapsules) (left vertical axis), and water content (right vertical axis) of yeast cells (Standard 2-D). Axis) relationship is shown. Black circles indicate the comprehensive ratio, and white circles indicate the water content. 図2は、マイクロカプセル中のフレーバーと酵母(標品2)の混合割合(フレーバー/酵母)とフレーバーの包括率(mg/粉末マイクロカプセル)(左縦軸)及び包括効率(%)(右縦軸)の関係を示す。四角はフレーバー包括率、菱形は包括効率を示す。図2Aは、酵素や乳化剤で処理せず、噴霧乾燥(スプレードライ)し得た酵母細胞を用いた酵母マイクロカプセル(標品2-S)の結果、図2Bは、酵素や乳化剤で処理せず、加熱乾燥(ドラムドライ)して得た酵母細胞(標品2-D)を用いた酵母マイクロカプセルの結果を示す。FIG. 2 shows the mixing ratio (flavor / yeast) of flavor and yeast (standard 2) in microcapsules, flavor inclusion ratio (mg / powder microcapsules) (left vertical axis), and inclusion efficiency (%) (right vertical). Axis) relationship is shown. The squares indicate the flavor inclusion rate, and the diamonds indicate the inclusion efficiency. FIG. 2A shows yeast microcapsules (standard product 2-S) using yeast cells that could be spray-dried without being treated with an enzyme or emulsifier. As a result, FIG. 2B was not treated with an enzyme or emulsifier. The results of yeast microcapsules using yeast cells (standard 2-D) obtained by heating and drying (drum drying) are shown. 図3は、マイクロカプセル中のフレーバーと酵母の混合割合(フレーバー/酵母)とフレーバーの包括率(mg/粉末マイクロカプセル)(左縦軸)の関係を示す。黒塗りのグラフは、標品1-Dを用いた結果、網掛けのグラフは標品2-Dを用いた結果を示す。FIG. 3 shows the relationship between the mixing ratio of flavor and yeast in microcapsules (flavor / yeast) and the flavor inclusion ratio (mg / powder microcapsules) (left vertical axis). The black-painted graph shows the result of using the standard 1-D, and the shaded graph shows the result of using the standard 2-D. 図4は、噴霧乾燥空気入口温度とフレーバー包括率(mg/粉末マイクロカプセル)の関係を示す。丸型は、標品1-Dとd-リモネンの包括率、菱形は標品2-Dとd-リモネンの包括率、四角は、標品1-Dの含水率、三角は標品2-Dの含水率の結果を示す。FIG. 4 shows the relationship between the spray-dried air inlet temperature and the flavor inclusion ratio (mg / powder microcapsules). The round shape is the comprehensive ratio of the standard 1-D and d-limonene, the diamond is the comprehensive ratio of the standard 2-D and d-limonene, the square is the water content of the standard 1-D, and the triangular is the standard 2-. The result of the water content of D is shown. 図5は、内容成分が抽出された細胞、第2有効成分及び水の混合液の攪拌時間と、フレーバー包括率(mg/粉末マイクロカプセル)の関係を示す。四角は、標品1-Dとd-リモネン、丸型は標品2-Dとd-リモネン、菱形は、標品1-Dとカプロン酸エチル、三角は標品2-Dとカプロン酸エチルの結果を示す。FIG. 5 shows the relationship between the stirring time of the mixture of the cells from which the content component was extracted, the second active ingredient and water, and the flavor inclusion ratio (mg / powder microcapsules). Squares are specimens 1-D and d-limonene, rounds are specimens 2-D and d-limonene, rhombuses are specimens 1-D and ethyl caproate, and triangles are specimens 2-D and ethyl caproate. The result of is shown. 図6は、内容成分が抽出された細胞(標品1)、第2有効成分及び水の混合液の攪拌温度と、フレーバー包括率(mg/粉末マイクロカプセル)の関係を示す。各温度の右側の黒色グラフがカプロン酸エチル、左側の網掛けグラフがd-リモネンの結果を示す。FIG. 6 shows the relationship between the stirring temperature of the cell (standard 1) from which the content component was extracted, the second active ingredient and the mixed solution of water, and the flavor inclusion ratio (mg / powder microcapsules). The black graph on the right side of each temperature shows the result of ethyl caproate, and the shaded graph on the left side shows the result of d-limonene. 図7は、内容成分が抽出された細胞(標品2)、第2有効成分及び水の混合液の攪拌温度と、フレーバー包括率(mg/粉末マイクロカプセル)の関係を示す。FIG. 7 shows the relationship between the stirring temperature of the cell from which the content component was extracted (standard product 2), the second active ingredient and the mixed solution of water, and the flavor inclusion ratio (mg / powder microcapsules). 図8は、酵素や乳化剤で処理せず、噴霧乾燥(スプレードライ)し得た酵母細胞(標品2-S)を用いた酵母マイクロカプセルの構造を走査形電子顕微鏡を用いて観察した結果を示す。左から、フレーバーを含まない対照マイクロカプセル、カプロン酸エチルを含むマイクロカプセル、d-リモネンを含むカプセルである。上段及び中段は3000倍、下段は10,000倍の顕微鏡写真である。FIG. 8 shows the results of observing the structure of yeast microcapsules using yeast cells (grade 2-S) obtained by spray drying without treatment with an enzyme or emulsifier using a scanning electron microscope. show. From the left, flavor-free control microcapsules, microcapsules containing ethyl caproate, and capsules containing d-limonene. The upper and middle tiers are 3,000 times micrographs, and the lower tiers are 10,000 times micrographs. 図9は、酵素や乳化剤で処理せず、ドラムドライし得た酵母細胞(標品2-D)を用いた酵母マイクロカプセルの構造を走査形電子顕微鏡を用いて観察した結果を示す。左から、フレーバーを含まない対照マイクロカプセル、カプロン酸エチルを含むマイクロカプセル、d-リモネンを含むカプセルである。上段及び中段は3000倍、下段は10,000倍の顕微鏡写真である。FIG. 9 shows the results of observing the structure of yeast microcapsules using yeast cells (standard 2-D) that could be drum-dried without treatment with an enzyme or emulsifier using a scanning electron microscope. From the left, flavor-free control microcapsules, microcapsules containing ethyl caproate, and capsules containing d-limonene. The upper and middle tiers are 3,000 times micrographs, and the lower tiers are 10,000 times micrographs. 図10は、酵素処理、乳化剤処理を行い噴霧乾燥した酵母細胞(標品1-D)を用いた酵母マイクロカプセルの構造を走査形電子顕微鏡を用いて観察した結果を示す。上段はカプセル化前の酵母細胞(標品1-D)であり、下段がd-リモネンを含むマイクロカプセルである。上段は3000倍、左下段は5000倍、右下段は1500倍の顕微鏡写真である。FIG. 10 shows the results of observing the structure of yeast microcapsules using yeast cells (standard 1-D) that had been subjected to enzyme treatment and emulsifier treatment and spray-dried using a scanning electron microscope. The upper row is yeast cells before encapsulation (standard 1-D), and the lower row is microcapsules containing d-limonene. The upper row is a photomicrograph of 3000 times, the lower left is a photograph of 5000 times, and the lower right is a photomicrograph of 1500 times. 図11は、マイクロカプセルの徐放挙動を調べた結果である。横軸は、マイクロカプセルを製造し乾燥条件又は湿潤条件を課してからの時間(分)、縦軸はフレーバー残留率を示す。左は、乾燥条件徐放、右は、湿潤条件(100重量%)徐放である。上段はカプロン酸エチルを含むマイクロカプセルの結果、下段はd-リモネンを含むカプセルの結果である。FIG. 11 shows the results of investigating the sustained release behavior of microcapsules. The horizontal axis shows the time (minutes) after the microcapsules are manufactured and the drying condition or the wetting condition is applied, and the vertical axis shows the flavor residual rate. The left is a sustained release under dry conditions, and the right is a sustained release under wet conditions ( 100% by weight ). The upper row is the result of microcapsules containing ethyl caproate, and the lower row is the result of capsules containing d-limonene. 図12は、マイクロカプセルの酸化安定性を調べた結果である。横軸は、マイクロカプセルを105℃の酸化条件下に供した保存期間(日)である。縦軸は、リモネン酸化物放出率(mg/粉末マイクロカプセル)(図12A)及び、カルボン放出率(mg/粉末マイクロカプセル)(図12B)である。丸印は、標品2-Dをカプセル化したもの、四角は、標品2-Dを酸処理しカプセル化したもの(比較例1)、そして、▲はデキストリンの噴霧乾燥品の結果である。FIG. 12 shows the results of examining the oxidative stability of microcapsules. The horizontal axis is the storage period (days) when the microcapsules are subjected to oxidation conditions at 105 ° C. The vertical axis is the limonene oxide release rate (mg / powder microcapsules) (FIG. 12A) and the carvone release rate (mg / powder microcapsules) (FIG. 12B). The circles are the encapsulated preparations 2-D, the squares are the acid-treated and encapsulated preparations 2-D (Comparative Example 1), and the ▲ are the results of the spray-dried dextrin. .. 図13は、植物性タンパク質のみ(試験区1)、乳酸菌・酵母発酵物を添加(試験区2)、酵母マイクロカプセルを添加(試験区3)、乳酸菌・酵母発酵物及び酵母マイクロカプセルの両者を添加(試験区4)の各試験区について、GC-MS測定を行い、各試験区のヘキサナールにあたるGCピークの総面積を示した図である(上から、試験区1~試験区4)。FIG. 13 shows only vegetable protein (test group 1), lactic acid bacteria / yeast fermented product added (test group 2), yeast microcapsules added (test group 3), both lactic acid bacteria / yeast fermented product and yeast microcapsules. It is a figure which performed GC-MS measurement for each test group of addition (test group 4) and showed the total area of the GC peak corresponding to hexanal of each test group (from the top, test group 1 to test group 4).

非限定的に、第2有効成分の包括効率は、好ましくは、少なくとも10%、20%、30%、40%、50%、60%、80%である。第2有効成分の包括効率は混合に用いた第2有効成分のうち、マイクロカプセルの包括された第2有効成分の割合である。マイクロカプセルに包括された第2有効成分の定量は、定量が可能なガスクロマトグラフィー等の手段、例えば、ガスクロマトグラフィー-水素炎イオン化型検出器を用いて行うことができる。酵素処理、乳化剤処理を行った酵母マイクロカプセルはそれらの処理を行わない酵母マイクロカプセルと比較しても高い包括効率が得られる。 Non-limitingly, the inclusive efficiency of the second active ingredient is preferably at least 10%, 20%, 30%, 40%, 50%, 60% and 80%. The comprehensive efficiency of the second active ingredient is the ratio of the comprehensive second active ingredient of the microcapsules to the second active ingredient used for mixing. The quantification of the second active ingredient contained in the microcapsules can be performed by means such as gas chromatography capable of quantification, for example, a gas chromatography-hydrogen flame ionization detector. Yeast microcapsules treated with enzymes and emulsifiers can obtain high comprehensive efficiency as compared with yeast microcapsules not treated with them.

一態様において、乳化剤は、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、レシチン及びサポニンからなる群より選択される。また、乳化剤は、1種を単独で、又は2種以上を混合して内容成分が分離され残留した酵母細胞に添加してもよい。 In one embodiment, the emulsifier is selected from the group consisting of glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, sucrose fatty acid ester, lecithin and saponin . In addition, the emulsifier may be added to yeast cells in which the content components have been separated and remain, either alone or in combination of two or more.

「有効成分として含有する」とは、マイクロカプセルが風味向上効果を奏する程度に含有していれば特に限定されない。一態様において、風味向上剤中、マイクロカプセルを30質量%以上、50質量%以上、より好ましくは70質量%以上、更に好ましくは90質量%以上含有することを意味する。風味向上剤は、食品又は飲料に添加することができる。本発明のマイクロカプセルを含む風味向上剤は、乾燥状態のものであっても、ペースト状(ペースト品)であってもよい。 The term "contained as an active ingredient" is not particularly limited as long as the microcapsules are contained to such an extent that they have a flavor-enhancing effect. In one embodiment, it means that the flavor improver contains 30% by mass or more, 50% by mass or more, more preferably 70% by mass or more, and further preferably 90% by mass or more of microcapsules. Flavor enhancers can be added to foods or beverages. The flavor improving agent containing the microcapsules of the present invention may be in a dry state or in the form of a paste (paste product).

(4)フレーバーと酵母の混合割合の検討
実施例2(1)と同様の酵母マイクロカプセル作成において、実施例1で得た未処理の酵母細胞(標品2)を用いて、混合するカプロン酸エチル(フレーバー)と酵母細胞の比を変化させた場合のカプロン酸エチルの包括率を検討した。フレーバーの包括率の算出は、実施例2(3)と同様に行った。
(4) Examination of mixing ratio of flavor and yeast In the yeast microcapsule preparation similar to Example 2 (1), the untreated yeast cells (standard 2) obtained in Example 1 are used to mix caproic acid. The inclusion rate of ethyl caproate when the ratio of ethyl (flavor) to yeast cells was changed was examined. The flavor inclusion rate was calculated in the same manner as in Example 2 (3).

実施例3 酵母マイクロカプセルの形状
本実施例において、酵母マイクロカプセルの形状を調べた。
具体的には、フレーバーとしてカプロン酸エチル又はd-リモネンを各々、噴霧乾燥処理又は加熱乾燥(ドラムドライ)処理した標品2に各々カプセル化して、酵母マイクロカプセルを製造した。また、標品1原体と、標品1をカプセル化した酵母カプセルをそれぞれ製造した。得られた各々の物質構造を、走査型電子顕微鏡(JSM-6060、日本電子株式会社、東京、日本)を用いて観察した。具体的には、酵母マイクロカプセルをφ8mm丸形カーボンテープ(日新EM株式会社、東京、日本)を試料台につけ、スパーテルを用いてテープに少量のせた。それを、マグネトロンスパッタ装置(MPS-1S,(株)真空デバイス、茨城、日本)に設置し、Pt-Pd電子を付着させた。試料ホルダに試料台を入れ、電子顕微鏡に取り付け、観察した。
Example 3 Shape of yeast microcapsules In this example, the shape of yeast microcapsules was investigated.
Specifically, ethyl caproate or d-limonene as flavors were encapsulated in the standard 2 which had been spray-dried or heat-dried (drum-dried), respectively, to produce yeast microcapsules. In addition, a sample 1 drug substance and a yeast capsule in which the sample 1 was encapsulated were produced. Each of the obtained material structures was observed using a scanning electron microscope (JSM-6060, JEOL Ltd., Tokyo, Japan). Specifically, yeast microcapsules were attached to a φ8 mm round carbon tape (Nisshin EM Co., Ltd., Tokyo, Japan) on a sample table, and a small amount was placed on the tape using a spatula. It was installed in a magnetron sputtering device (MPS-1S, Vacuum Device Co., Ltd., Ibaraki, Japan), and Pt-Pd electrons were attached. The sample table was placed in the sample holder, attached to an electron microscope, and observed.

実施例1で得た標品2-Sおよび2-Dを用いて、実施例2(2)と同様の標品2-Sおよび2-Dの粉末酵母マイクロカプセルを作成した。80℃の乾燥条件及び100%湿潤条件における酵母マイクロカプセルのフレーバー徐放挙動を観察した。フレーバー徐放量は、酵母粉末中のフレーバー量の変化によって検討した。 Using the preparations 2-S and 2-D obtained in Example 1, powdered yeast microcapsules of the preparations 2-S and 2-D similar to those in Example 2 (2) were prepared. The flavor sustained release behavior of yeast microcapsules under dry conditions of 80 ° C. and 100% wet conditions was observed. The sustained release amount of flavor was examined by the change in the amount of flavor in the yeast powder.

実施例6 酵母マイクロカプセルの酸化安定性及び徐放効果の検証
本実施例では、酵母マイクロカプセルの酸化安定性試験を行った。
実施例1で得た標品2-Dを用いて実施例2(2)と同様の標品2-Dの粉末酵母マイクロカプセルを作成した。フレーバーは、リモネンを使用し、その酸化物であるリモネン酸化物とカルボンの放出を測定することにより、その酸化の早さを測定した。比較例として、比較例1の方法で標品2-Dを塩酸で処理した後、実施例2(2)と同様の方法で酵母マイクロカプセルを作製した。また、対照として、デキストリンを噴霧乾燥したカプセルを作成した。次いで、105℃乾燥条件下での酸化安定性試験により、それぞれの酵母マイクロカプセルの徐放挙動を観察した。
Example 6 Verification of oxidative stability and sustained-release effect of yeast microcapsules In this example, the oxidative stability test of yeast microcapsules was performed.
Using the standard 2-D obtained in Example 1, powdered yeast microcapsules of the standard 2-D similar to Example 2 (2) were prepared. The flavor used limonene and measured the rate of its oxidation by measuring the release of its oxides, limonene oxide and carvone. As a comparative example, after treating the standard 2-D with hydrochloric acid by the method of Comparative Example 1, yeast microcapsules were prepared by the same method as in Example 2 (2). Also, as a control, capsules spray-dried with dextrin were prepared. Then, the sustained release behavior of each yeast microcapsule was observed by an oxidative stability test under a drying condition of 105 ° C.

リモネン包括酵母マイクロカプセルの3%水溶液を作成し、官能評価及び臭気センサー測定を行った。具体的には、実施例1で得た酵母細胞(標品1-S及び標品2-S):リモネン:水=2:1:7、40℃、1時間撹拌し、フレーバー分散液を作成することで、ペースト状の酵母マイクロカプセルを得た(標品1-P及び標品2-P)。80℃お湯に標品1-Pおよび標品2-Pを3%添加して撹拌し、リモネン香と酵母臭について官能評価を行った。官能評価は、専門のパネラー5名で行った。臭気センサー測定は、官能評価を実施した後、1分間測定したときの最大値を結果とした。結果は、以下の表の通りである。 A 3% aqueous solution of limonene-containing yeast microcapsules was prepared, and sensory evaluation and odor sensor measurement were performed. Specifically, the yeast cells (standard 1-S and standard 2-S) obtained in Example 1: Limonen: water = 2: 1: 7, 40 ° C., stirred for 1 hour to prepare a flavor dispersion. By doing so, paste-like yeast microcapsules were obtained (Standard 1-P and Standard 2-P). 3% of the standard 1-P and the standard 2-P were added to hot water at 80 ° C. and stirred, and the limonene aroma and the yeast odor were sensory evaluated. The sensory evaluation was performed by 5 specialized panelists. For the odor sensor measurement , the maximum value when measured for 1 minute after performing the sensory evaluation was used as the result. The results are shown in the table below.

又、香辛料抽出物を展開した場合には、喫食後すぐに風味、香りを感じたが(風味発現速度早い)、酵母マイクロカプセル化した香辛料抽出物を加えたものは喫食直後には風味、香りの立ち上がりは弱いものの、しばらくしたのちに徐々に風味、香りを感じ、最終的には香辛料抽出物そのものを加えたものより強い風味、香りを感じた。 In addition, when the spice extract was developed, the flavor and aroma were felt immediately after eating (flavor onset rate was fast), but the one with the spice extract encapsulated in yeast microencapsulated had the flavor and aroma immediately after eating. Although the rise was weak, after a while, the flavor and aroma were gradually felt, and finally, the flavor and aroma were stronger than those to which the spice extract itself was added.

本発明のブラックペッパー抽出物包括酵母マイクロカプセル(標品1-P)を加えた試験区3、試験区4では、試験区1と比較し、GC-MSのピークの総面積では、ヘキサナールの量が減少した。
発酵液(CN-2)を添加した試験区2では、ヘキサナールの挙動に変化がなかった。
In Test Group 3 and Test Group 4 to which the black pepper extract-containing yeast microcapsules (Standard 1-P) of the present invention were added, the amount of hexanal in the total area of the peak of GC-MS was compared with that of Test Group 1. Has decreased.
In Test Group 2 to which the fermented liquid (CN-2) was added, there was no change in the behavior of hexanal.

試験区3の結果から、酵母マイクロカプセル添加により、カプセル内にあるブラップペッパーが徐放され、臭いと風味が改善されたことが示唆される。更に、試験区4のように、発酵液(CN-2)と酵母マイクロカプセルを併用することで、発酵液がカプセル内に取り込まれ、酵母マイクロカプセルから発酵液が徐放されることで、長時間の植物性タンパク質臭抑制効果として働くことが示唆される。 The results of Test Group 3 suggest that the addition of yeast microcapsules sustained the release of the flap peppers in the capsules, improving the odor and flavor. Furthermore, as in Test Group 4, by using the fermented liquid (CN-2) and yeast microcapsules in combination, the fermented liquid is taken into the capsule, and the fermented liquid is gradually released from the yeast microcapsules. It is suggested that it works as an effect of suppressing the odor of vegetable protein in time.

Claims (23)

マイクロカプセルの製造方法であって、
酵母細胞を熱水処理し、内容成分が菌体外に放出され、内容成分が分離され残留した酵母細胞を製造する工程、
前記内容成分が分離され残留した酵母細胞にプロテアーゼ及び/又はセルラーゼ添加処理を施す工程、
前記内容成分が分離され残留した酵母細胞にプロテアーゼ及び/又はセルラーゼ添加処理を施す工程の前、後、又は同時に乳化剤を添加する工程を含む、
前記内容成分が分離され残留した酵母細胞を第1有効成分とし、これに第2有効成分を内包させる工程、
を含む、
ただし、内容成分が分離され残留した酵母細胞に酸処理を施さない、
前記製造方法。
It ’s a method of manufacturing microcapsules.
A process of treating yeast cells with hot water, releasing the content components to the outside of the cells, separating the content components, and producing residual yeast cells.
A step of applying a protease and / or cellulase addition treatment to the yeast cells from which the content components have been separated and remained.
A step of adding an emulsifier before, after, or at the same time as applying a protease and / or cellulase addition treatment to the yeast cells from which the content components have been separated and remaining is included.
A step of using yeast cells from which the above-mentioned content components have been separated and remaining as the first active ingredient and incorporating the second active ingredient into the first active ingredient.
including,
However, the yeast cells from which the content components have been separated and remain are not treated with acid.
The manufacturing method.
乳化剤が、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、レシチン及びサポニンからなる群より選択される、請求項1に記載の方法。 The method according to claim 1 , wherein the emulsifier is selected from the group consisting of glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, sucrose fatty acid ester, lecithin and saponin . 第2有効成分が、香料、香辛料抽出物、香味油、動物性油脂及び植物性油脂からなる群から選択される脂溶性物質である、請求項1又は2に記載の方法。 The method according to claim 1 or 2 , wherein the second active ingredient is a fat-soluble substance selected from the group consisting of fragrances, spice extracts, flavor oils, animal fats and oils, and vegetable fats and oils. 内容成分が分離され残留した酵母細胞が、乾燥された状態のものである、請求項1-3のいずれか1項に記載の方法。 The method according to any one of claims 1-3 , wherein the yeast cells from which the content components have been separated and remain are in a dried state. 内容成分が分離され残留した酵母細胞が、タンパク質成分を45重量%-70重量%の範囲で含有する、請求項1-4のいずれか1項に記載の方法。 The method according to any one of claims 1-4 , wherein the yeast cells from which the content components have been separated and remain contain the protein components in the range of 45% by weight to 70% by weight. 前記内容成分が分離され残留した酵母細胞に第2有効成分を内包させる工程が、内容成分が分離され残留した酵母細胞、第2有効成分及び水分を混合して攪拌することを含む、請求項1-5のいずれか1項に記載の方法。 1. The step of encapsulating the second active ingredient in the yeast cells from which the content component has been separated and remaining comprises mixing and stirring the yeast cell from which the content component has been separated and remaining, the second active ingredient and water. -The method according to any one of 5 . 前記内容成分が分離され残留した酵母細胞に第2有効成分を内包させる工程が、内容成分が分離され残留した酵母細胞、第2有効成分及び水分を混合して攪拌し、得られた分散液を乾燥することを含む、請求項1-6のいずれか1項に記載の方法。 In the step of encapsulating the second active ingredient in the yeast cells from which the content component was separated and remained, the yeast cells from which the content component was separated and remained, the second active ingredient and water were mixed and stirred, and the obtained dispersion was obtained. The method according to any one of claims 1-6 , which comprises drying. 内容成分が分離され残留した酵母細胞と第2有効成分の混合割合が、4:1-1:1の範囲である、請求項6又は7に記載の方法。 The method according to claim 6 or 7 , wherein the mixing ratio of the yeast cells in which the content component is separated and remains and the second active ingredient is in the range of 4: 1-1: 1. 攪拌時間が1時間以上8時間以内である、請求項6-8のいずれか1項に記載の方法。 The method according to any one of claims 6-8 , wherein the stirring time is 1 hour or more and 8 hours or less. 攪拌温度が25℃以上50℃未満である、請求項6-9のいずれか1項に記載の方法。 The method according to any one of claims 6-9 , wherein the stirring temperature is 25 ° C. or higher and lower than 50 ° C. 第2有効成分の包括効率が少なくとも40%である、請求項1-10のいずれか1項に記載の方法。 The method according to any one of claims 1-10 , wherein the comprehensive efficiency of the second active ingredient is at least 40%. 請求項1-11のいずれか1項に記載の方法により製造され、内容成分が分離され残留した酵母細胞及び第2有効成分を含み、そして、酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、第2有効成分の徐放性が向上している、マイクロカプセル。 A yeast cell produced by the method according to any one of claims 1-11 , containing a yeast cell and a second active ingredient whose contents have been separated and remained, and which has been acid-treated, the contents have been separated and remained. Microcapsules with improved sustained release of the second active ingredient as compared to microcapsules obtained using yeast cells . 酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、同等の酸化安定性である、請求項12に記載のマイクロカプセル。 The microcapsule according to claim 12, which has equivalent oxidative stability as compared with microcapsules obtained by using yeast cells which have been subjected to acid treatment and whose contents have been separated and remained. 第2有効成分を5重量%以上含む、請求項12又は13のいずれか1項に記載のマイクロカプセル。 The microcapsule according to any one of claims 12 or 13 , which contains 5% by weight or more of the second active ingredient. 第2有効成分が香料、香辛料抽出物、動物性油脂、香味油及び植物性油脂からなる群から選択される脂溶性物質である、請求項12-14のいずれか1項に記載のマイクロカプセル。 The microcapsule according to any one of claims 12-14 , wherein the second active ingredient is a fat-soluble substance selected from the group consisting of fragrances, spice extracts, animal fats and oils, flavor oils and vegetable fats and oils. ペースト状である、請求項12-15のいずれか1項に記載のマイクロカプセル。 The microcapsule according to any one of claims 12 to 15, which is in the form of a paste. 冷蔵保存され得る、請求項12-16のいずれか1項に記載のマイクロカプセル。 The microcapsule according to any one of claims 12-16 , which can be stored refrigerated. 請求項12-17のいずれか1項に記載のマイクロカプセルを含む、食品又は飲料の風味向上剤。 A food or beverage flavor enhancer comprising the microcapsules according to any one of claims 12-17 . 請求項12-17のいずれか1項に記載のマイクロカプセル、あるいは、請求項18に記載の風味向上剤を含む、食品又は飲料。 A food or beverage comprising the microcapsule according to any one of claims 12-17 or the flavor enhancer according to claim 18 . レトルト食品である、請求項19に記載の食品。 The food product according to claim 19 , which is a retort food product. (1)請求項1-11のいずれか1項に記載の方法により製造され、内容成分が分離され残留した酵母細胞及び第2有効成分を含み、そして、酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、第2有効成分の徐放性が向上している、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を含む、植物性タンパク質臭を抑制するための組成物。
(1) The content component produced by the method according to any one of claims 1-11 , containing yeast cells and a second active ingredient whose content components have been separated and remained , and which has been subjected to acid treatment. Microcapsules with improved sustained release of the second active ingredient as compared to microcapsules obtained using isolated and residual yeast cells , and (2) those having a vegetable protein odor suppressing effect. A composition for suppressing the odor of vegetable protein, including.
(1)請求項1-11のいずれか1項に記載の方法により製造され、内容成分が分離され残留した酵母細胞及び第2有効成分を含み、そして、酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、第2有効成分の徐放性が向上している、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を含む、食品又は飲料。
(1) The content component produced by the method according to any one of claims 1-11 , containing yeast cells and a second active ingredient whose content components have been separated and remained , and which has been subjected to acid treatment. Microcapsules with improved sustained release of the second active ingredient as compared to microcapsules obtained using isolated and residual yeast cells , and (2) those having a vegetable protein odor suppressing effect. Including food or beverage.
(1)請求項1-11のいずれか1項に記載の方法により製造され、内容成分が分離され残留した酵母細胞及び第2有効成分を含み、そして、酸処理を施した、内容成分が分離され残留した酵母細胞を用いて得られたマイクロカプセルと比較して、第2有効成分の徐放性が向上している、マイクロカプセル、及び
(2)植物性タンパク質臭抑制効果を有する物
を添加することを含む、植物性タンパク質臭を抑制するための方法。
(1) The content component produced by the method according to any one of claims 1-11 , containing yeast cells and a second active ingredient whose content components have been separated and remained , and which has been subjected to acid treatment. Microcapsules with improved sustained release of the second active ingredient as compared to microcapsules obtained using isolated and residual yeast cells , and (2) those having a vegetable protein odor suppressing effect. A method for suppressing vegetable protein odor, including addition.
JP2020517071A 2018-05-01 2019-04-26 microcapsule Active JP7341128B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018088182 2018-05-01
JP2018088182 2018-05-01
PCT/JP2019/018037 WO2019212050A1 (en) 2018-05-01 2019-04-26 Microcapsule

Publications (3)

Publication Number Publication Date
JPWO2019212050A1 JPWO2019212050A1 (en) 2021-05-27
JPWO2019212050A5 true JPWO2019212050A5 (en) 2022-04-19
JP7341128B2 JP7341128B2 (en) 2023-09-08

Family

ID=68386094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020517071A Active JP7341128B2 (en) 2018-05-01 2019-04-26 microcapsule

Country Status (4)

Country Link
JP (1) JP7341128B2 (en)
KR (1) KR20210004970A (en)
CN (1) CN112055611A (en)
WO (1) WO2019212050A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7426806B2 (en) * 2019-11-11 2024-02-02 テーブルマーク株式会社 Composition or combination for lowering blood sugar level or GI level
JP7019783B2 (en) * 2019-11-15 2022-02-15 マルハニチロ株式会社 Meat pickled processed food
CN113528093A (en) * 2021-06-18 2021-10-22 东南大学 Yeast cell wall-coated phase-change material microcapsule and preparation method and application thereof
CN115212184A (en) * 2022-08-23 2022-10-21 怀化学院 Perilla seed oil nano-particles and preparation method and application thereof
CN115633771B (en) * 2022-10-26 2024-03-15 鲜之然(天津)生物技术有限公司 Pepper microcapsule and preparation method thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0732870B2 (en) * 1990-04-20 1995-04-12 三菱製紙株式会社 Microcapsule manufacturing method
JP3055376B2 (en) * 1993-09-30 2000-06-26 不二製油株式会社 Milk-flavored soy protein composition and method for producing the same
JP3769057B2 (en) * 1994-11-17 2006-04-19 麒麟麦酒株式会社 Method for producing microcapsules
GB9509937D0 (en) * 1995-05-17 1995-07-12 Cpc International Inc Encapsulated product
JPH09107919A (en) * 1995-10-17 1997-04-28 Meiji Seika Kaisha Ltd Material for supplying magnesium, its production and use
JP2005137322A (en) * 2003-11-10 2005-06-02 Sanei Gen Ffi Inc Candy added with heat-resistant spice pharmaceutical preparation
DE602005004114T3 (en) * 2005-02-18 2016-10-27 Gnosis S.P.A. Process for the preparation of yeast microcapsules
CN100544815C (en) * 2007-07-01 2009-09-30 石国荣 A kind of method of utilizing the microcapsule wall material of yeast cell to prepare safety non-toxic good property
JP4866386B2 (en) 2008-05-02 2012-02-01 三栄源エフ・エフ・アイ株式会社 Yeast microencapsulated flavor and / or spice extract with enhanced and improved flavor and flavor expression
JP5308219B2 (en) * 2009-04-14 2013-10-09 三栄源エフ・エフ・アイ株式会社 Meat or fish processed food containing soy protein with improved flavor
RU2654748C2 (en) 2013-02-25 2018-05-22 Фирмениш Са Encapsulated plasmolysed micro-organism particles
CN104336574B (en) * 2014-11-10 2019-08-20 天津春发生物科技集团有限公司 A kind of method that biology-frozen drying method prepares yeast microcapsules
TWI674070B (en) 2014-11-19 2019-10-11 日商泰寶美客股份有限公司 Method of improving flavor of yeast cells and food quality improvement agent
KR20180030059A (en) 2015-07-21 2018-03-21 테이부루마크 가부시키가이샤 Novel fermented seasoning composition
JP2018057309A (en) * 2016-10-04 2018-04-12 株式会社和冠 Masking composition for reducing unpleasant odor of food

Similar Documents

Publication Publication Date Title
JPWO2019212050A5 (en)
JP7341128B2 (en) microcapsule
JP3970540B2 (en) Coating agent and coating powder
EP2339927B1 (en) Puffed starch material
JP4393385B2 (en) Rice flour production method and its use
US20060172052A1 (en) Edible product comprising flavoring microcapsules
EP1023842B1 (en) Edible powder material having excellent shelf stability
WO2016097294A1 (en) An oral smokeless moist snuff product
CN102746534A (en) Alginate matrix particles
BRPI0614186A2 (en) food comprising silence
JP2003306692A (en) Powdery oil-and-fat
JP6847582B2 (en) Dispersion composition containing liquid phase and processed microbial cell, and seasoning composition using yeast extract
JP2009518029A (en) Instant food containing flavor capsules
US20030077378A1 (en) Hydroxypropyl cellulose encapsulation material
US20090208604A1 (en) Fat, wax or oil-based food ingredient comprising encapsulated flavors
KR101920462B1 (en) Mineral curcumin drink and its manufacturing method
JP2019058128A (en) Flavor improvement method of chocolate to which pulverized black tea leaf is added, and chocolate manufactured by the method
JPS5912269B2 (en) flavoring agent
CN106028826A (en) Aroma-retaining soluble coffee
JPH0779712A (en) Preparation containing water-soluble hemicellulose
JP3872369B2 (en) Processed honoki leaves and method for producing the same
JP4556072B2 (en) Deodorant composition and deodorant
JP5599255B2 (en) Fat, wax or fat based food ingredients comprising encapsulated flavors
WO2022210840A1 (en) Oral pouch product and oral pouch product manufacturing method
JP7242282B2 (en) Improving agent for instant noodles